JOINN adheres to the purpose of "Serve for Drug Innovation,
Focus on Safety Assessments and Monitoring of Drugs Throughout Life Cycles"

Final dividend in cash for the year ended December 31, 2023

Final dividend in cash for the year ended December 31, 2023

MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 29 FEBRUARY 2024

MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 29 FEBRUARY 2024

POLL RESULTS OF THE FIRST EXTRAORDINARY GENERAL MEETING OF 2024, THE FIRST A SHARE CLASS MEETING FOR 2024 AND THE FIRST H SHARE CLASS MEETING FOR 2024

POLL RESULTS OF THE FIRST EXTRAORDINARY GENERAL MEETING OF 2024, THE FIRST A SHARE CLASS MEETING FOR 2024 AND THE FIRST H SHARE CLASS MEETING FOR 2024

CHANGE OF VENUE OF THE FIRST EXTRAORDINARY GENERAL MEETING OF 2024 AND THE FIRST H SHARE CLASS MEETING TO BE HELD ON TUESDAY, 27 FEBRUARY 2024

CHANGE OF VENUE OF THE FIRST EXTRAORDINARY GENERAL MEETING OF 2024 AND THE FIRST H SHARE CLASS MEETING TO BE HELD ON TUESDAY, 27 FEBRUARY 2024

ANNOUNCEMENT PURSUANT TO RULES 13.51B(2) AND 13.51(2) OF THE LISTING RULES

ANNOUNCEMENT PURSUANT TO RULES 13.51B(2) AND 13.51(2) OF THE LISTING RULES

MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JANUARY 2024

MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JANUARY 2024

Notification Letter to Registered Shareholders and Reply Form

Notification Letter to Registered Shareholders and Reply Form

Leave us a message

Thank you for your attention to JOINN. Please fill in the information below, and we will contact you promptly.

Message

Message

top